This is a cross-sectional study including patients with permanent atrial fibrillation. Assessment will include: * clinic blood pressure measurements (mercury sphygmomanometer and automated oscillometric device) * 24-hour ambulatory blood pressure monitoring * determination of various serum markers and cardiac ultrasound. * evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG
Study Type
OBSERVATIONAL
Enrollment
100
Hypertension Center, Third Internal Medicine Dpt, University of Athens
Athens, Greece
RECRUITINGBlood Pressure Measurement in Atrial Fibrillation,Serum Markers and echocardiographic indexes in atrial fibrillation (AF)
1. Evaluation of the oscillometric technique of an electronic device in blood pressure measurement. 2. Evaluation of the relationship of blood pressure levels with serum markers and ultrasonographic cardiac indexes. 3. Evaluation of a 24h ambulatory blood pressure monitoring device (Microlife WatchBPO3) in terms of its diagnostic value for the detection of atrial fibrillation compared with the reference 24h Holter ECG
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.